Results 31 to 40 of about 279,056 (306)
Mìžnarodnij Endokrinologìčnij Žurnal, 2013 In this article authors discussed the results of literature review, which has been dedicated to study of different complications of growth hormone deficiency in adults, referring to the literature of the last 10–15 years.
S.I. Ismailov +3 more
doaj +1 more source
Optimizing Patient Management and Adherence for Children Receiving Growth Hormone. [PDF]
, 2017 Poor adherence with growth hormone (GH) therapy has been associated with worse clinical outcomes, which in children relates specifically to their linear growth and loss of quality of life.
Carlo L. Acerini +3 more
core +3 more sources
Growth Hormone Stimulation Testing: To Test or Not to Test? That Is One of the Questions
Frontiers in Endocrinology, 2022 The evaluation of children with short stature includes monitoring over a prolonged period to establish a growth pattern as well as the exclusion of chronic medical conditions that affect growth.
Mabel Yau, Robert Rapaport
doaj +1 more source
Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength [PDF]
, 2015 Patients with acromegaly have a higher prevalence of vertebral fractures despite normal bone mineral density (BMD), suggesting that GH overexpression has adverse effects on skeletal architecture and strength. We used giant bovine GH (bGH) transgenic mice
Chavassieux, P +10 more
core +4 more sources
Growth hormone deficiency in cleft lip and palate patients [PDF]
Journal of Analytical Research in Clinical Medicine, 2015 Introduction: Failure to thrive (FTT) is relatively common among cleft patients, most commonly attributed to feeding problems during the first months of life.
Shahin AbdollahiFakhim +4 more
doaj +1 more source
Parathyroid localization [PDF]
, 1986 Twenty-nine consecutive patients with suspected primary hyperparathyroidism were examined preoperatively using ultrasound, sonographically guided fine needle aspiration, and aspirate immunostaining for PTH.
Borisch, B. +7 more
core +1 more source
Anales de Pediatría, 2018 Resumen: Introducción: La hormona de crecimiento humana recombinante biosimilar (rhGH) fue el primer medicamento autorizado por la Agencia Europea del Medicamento (EMA), en el año 2006, por la vía de registro biosimilar.
Juan Pedro López-Siguero +4 more
doaj +1 more source
Pituitary-adrenal axis in Prader Willi syndrome [PDF]
, 2016 Purpose: Prader Willi syndrome (PWS) is a rare genetic condition that has concurrent endocrinological insufficiencies. The presence of growth hormone deficiency has been well documented, but adrenal insufficiency (AI) is not widely reported. A review was
Edgar, Olivia S. +2 more
core +2 more sources
Differential Tissue Response to Growth Hormone in Mice [PDF]
, 2018 Growth hormone (GH) has been shown to act directly on multiple tissues throughout the body. Historically, it was believed that GH acted directly in the liver and only indirectly in other tissues via insulin‐like growth hormone 1 (IGF‐1).
Banerjee, Ronadip R. +4 more
core +2 more sources
Italian Journal of Pediatrics, 2019 Background The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant
A. Cattoni +5 more
doaj +1 more source